Soodla, P;
Simmons, R;
Huik, K;
Pauskar, M;
Jogeda, E-L;
Rajasaar, H;
Kallaste, E;
... Lutsar, I; + view all
(2018)
HIV incidence in the Estonian population in 2013 determined using the HIV-1 limiting antigen avidity assay.
HIV Medicine
, 19
(1)
pp. 33-41.
10.1111/hiv.12535.
Preview |
Text
Pillay_est_incidence_study_08.10.2016_final.pdf - Accepted Version Download (400kB) | Preview |
Abstract
OBJECTIVES: Estonia has one the highest number of new HIV diagnoses in the European Union, mainly among injecting drug users and heterosexuals. Little is known of HIV incidence, which is crucial for limiting the epidemic. Using a recent HIV infection testing algorithm (RITA) assay, we aimed to estimate HIV incidence in 2013. METHODS: All individuals aged ≥18 years newly-diagnosed with HIV in Estonia January- December 2013, except blood donors and those undergoing antenatal screening, were included. Demographic and clinical data were obtained from the Estonian Health Board and the Estonian HIV-positive patient database. Serum samples were tested for recent infection using the LAg-avidity EIA assay. HIV incidence was estimated based on previously published methods. RESULTS: Of 69,115 tested subjects, 286 (0.41%) were newly-diagnosed with HIV with median age of 33 years (IQR: 28–42) and 65% male. Self-reported routes of HIV transmission were mostly heterosexual contact (n = 157, 53%) and injecting drug use (n = 62, 21%); 64 (22%) were with unknown risk group. Eighty two (36%) were assigned recent, resulting in estimated HIV incidence of 0.06%, corresponding to 642 new infections in 2013 among the non-screened population. Incidence was highest (1.48%) among people who inject drugs. CONCLUSIONS: These high HIV incidence estimates in Estonia call for urgent action of renewed targeted public health promotion and HIV testing campaigns.
| Type: | Article |
|---|---|
| Title: | HIV incidence in the Estonian population in 2013 determined using the HIV-1 limiting antigen avidity assay |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1111/hiv.12535 |
| Publisher version: | http://doi.org/10.1111/hiv.12535 |
| Language: | English |
| Additional information: | © 2017 British HIV Association. This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| Keywords: | Science & Technology, Life Sciences & Biomedicine, Infectious Diseases, Eastern Europe, epidemiology, HIV, HIV serological assay, injecting drug users, recent HIV infection, recent infection testing algorithm, HIV/AIDS SURVEILLANCE, SEROLOGICAL ASSAYS, VIRAL LOAD, INFECTION, SEROCONVERSION, EPIDEMIOLOGY, TRANSMISSION, PREVENTION, MORTALITY, DISEASE |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Infection and Immunity UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute for Global Health UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute for Global Health > Infection and Population Health |
| URI: | https://discovery.ucl.ac.uk/id/eprint/1570078 |
Archive Staff Only
 |
View Item |
